The use of anti-TNFα medications for rheumatologic disease in pregnancy
Megan EB ClowseDivision of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, USAAbstract: Anti-TNFα medications have led to vast improvements in the treatment of inflammatory conditions, including rheumatoid arthritis and Crohn’s dis...
Saved in:
Main Author: | Megan EB Clowse (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008) -
ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008) -
Anti-TNF-Alpha Therapy and Systemic Vasculitis
by: Pierre-André Jarrot, et al.
Published: (2014) -
Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis
by: Ju Li, et al.
Published: (2021) -
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan
by: Ya-Chiao Hu, et al.
Published: (2019)